Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 0.82 -0.08 (-8.33%)
As of 04:32 AM Eastern

VRCI vs. YGEN, ABDX, GENI, PRM, AGL, GDR, IDHC, DMTR, LLAI, and LLA

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Abingdon Health (ABDX), GENinCode (GENI), Proteome Sciences (PRM), ANGLE (AGL), genedrive (GDR), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), LungLife AI (LLAI), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs. Its Competitors

Verici Dx (LON:VRCI) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

15.6% of Verici Dx shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 1.0% of Verici Dx shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Verici Dx has a beta of 1.59, indicating that its stock price is 59% more volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Verici Dx-110.99% -71.67% -26.14%
Yourgene Health -27.55%-27.06%-6.71%

In the previous week, Yourgene Health's average media sentiment score of 0.00 beat Verici Dx's score of -1.84 indicating that Yourgene Health is being referred to more favorably in the news media.

Company Overall Sentiment
Verici Dx Very Negative
Yourgene Health Neutral

Verici Dx has higher earnings, but lower revenue than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verici Dx£1.91M6.53-£6.56M-£0.03-28.45
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A

Summary

Yourgene Health beats Verici Dx on 8 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£12.49M£47.60M£6.05B£2.59B
Dividend YieldN/A3.93%5.73%5.31%
P/E Ratio-28.450.9385.194,395.15
Price / Sales6.53513.26597.83100,927.55
Price / Cash1.3111.4225.7727.90
Price / Book0.192.7712.628.02
Net Income-£6.56M£334.07B£3.32B£5.89B
7 Day Performance17.86%1.70%-0.04%0.24%
1 Month Performance65.00%0.29%8.73%2.10%
1 Year Performance-84.29%-2.77%78.10%141.22%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 0.83
-8.3%
N/A-83.7%£12.49M£1.91M-28.4519Negative News
Gap Down
High Trading Volume
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 5.91
-7.3%
N/A-34.3%£11.44M£6.82M-809.5984
GENI
GENinCode
N/AGBX 3.80
+14.6%
N/A-24.0%£10.90M£2.91M-161.702,300
PRM
Proteome Sciences
N/AGBX 2.10
-4.5%
N/A-32.3%£6.20M£4.53M-185.84240Gap Down
High Trading Volume
AGL
ANGLE
1.4858 of 5 stars
GBX 1.85
-6.0%
GBX 40
+2,062.2%
-78.2%£5.97M£2.62M-38.54650Gap Down
GDR
genedrive
N/AGBX 0.34
-10.5%
N/A-86.4%£3.49M£676K-15.7443Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.53
+10.4%
N/A+28.5%£3.08M£5.72B0.296,692
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-65.0%£1.16M£33.87K-0.2815Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:VRCI) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners